QUDEXY XR
Topiramate
- Strength
- 200 mg/1
- Form
- Capsule, Extended Release
Upsher-Smith Laboratories, LLC
Eprontia
Topiramate
Listed by Azurity Pharmaceuticals, Inc.
- Strength
- 25 mg/mL
- Form
- Solution
- Route
- Oral
What it contains
- Topiramate 25 mg/mL
FDA record
| Dosage form | Solution |
|---|---|
| Route | Oral |
| Approval route | NDA — original brand approval |
| NDC code | 52652-9001 |
| FDA application | NDA214679 |
| RxNorm concept | 2586427 |
| Package sizes listed | 3 |
| Marketed since | December 2021 |
Other products containing Topiramate
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
QUDEXY XR
Topiramate
- Strength
- 150 mg/1
- Form
- Capsule, Extended Release
Upsher-Smith Laboratories, LLC
QUDEXY XR
Topiramate
- Strength
- 50 mg/1
- Form
- Capsule, Extended Release
Upsher-Smith Laboratories, LLC
QUDEXY XR
Topiramate
- Strength
- 25 mg/1
- Form
- Capsule, Extended Release
Upsher-Smith Laboratories, LLC
QUDEXY XR
Topiramate
- Strength
- 100 mg/1
- Form
- Capsule, Extended Release
Upsher-Smith Laboratories, LLC
Topamax
topiramate
- Strength
- 100 mg/1
- Form
- Tablet, Coated
Janssen Pharmaceuticals, Inc.
Topamax
topiramate
- Strength
- 200 mg/1
- Form
- Tablet, Coated
Janssen Pharmaceuticals, Inc.
Topamax
topiramate
- Strength
- 25 mg/1
- Form
- Capsule, Coated Pellets
Janssen Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.